You are here

  • Home
  • Archive
  • Volume 7, Issue 4
  • Review: most selective serotonin reuptake inhibitors lead to adverse events that appear to outweigh the benefits in children

Article Text

Article menu
Download PDFPDF
Treatment
Review: most selective serotonin reuptake inhibitors lead to adverse events that appear to outweigh the benefits in children

https://doi.org/10.1136/ebn.7.4.106

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341–5.OpenUrlCrossRefPubMedWeb of Science

    Q Are selective serotonin reuptake inhibitors (SSRIs) safe for treating depression in children?

    METHODS

    Embedded ImageData sources:

    Medline, CINAHL, EMBASE/Excerpta Medica, and PsycINFO (to April 2003); Cochrane Library; reference lists; tables of contents; previous systematic reviews; Guideline Development Group information; and written requests to experts.

    Embedded ImageStudy selection and assessment:

    English language RCTs (or RCTs with English abstracts) that compared SSRIs with placebo in children (5–18 y) with depression; had adequate blinding, concealed allocation, and description of withdrawals; and were published in peer reviewed journals or reviewed in a report by the …

    View Full Text

    Footnotes

    • For correspondence: Dr C J Whittington, University College London, London, UK. c.whittingtonucl.ac.uk

    • Source of funding: no external funding.